Point72 Asia (Singapore) Pte. Ltd. Biotechnology

Point72 Asia (Singapore) Pte. Ltd.

$563 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
STTK Shattuck Labs, Inc.	$32.2M	$22.9 Million 0.0% of portfolio	28,908	Q2 2025 New
MRSN Mersana Therapeutics, Inc.	$590M	$22.2 Million 0.0% of portfolio	75,151	Q2 2025 New
HOWL Werewolf Therapeutics, Inc.	$35.4M	$21.9 Million 0.0% of portfolio	20,126	Q2 2025 New
TNYA Tenaya Therapeutics, Inc.	$31.4M	$21.4 Million 0.0% of portfolio	35,024	Q2 2025 New
PYXS Pyxis Oncology, Inc.	$36.5M	$21.2 Million 0.0% of portfolio	19,228	Q2 2025 New
FULC Fulcrum Therapeutics, Inc.	$340M	$20.9 Million 0.0% of portfolio	3,031	Q2 2025 New
IPSC Century Therapeutics, Inc.	$30.6M	$20.6 Million 0.0% of portfolio	36,884	Q2 2025 New
DNLI Denali Therapeutics Inc.	$1.77B	$19.2 Million 0.0% of portfolio	1,369	Q2 2025 New
ELYM Eliem Therapeutics, Inc.	$109M	$17.5 Million 0.0% of portfolio	14,085	Q2 2025 New
ANNX Annexon, Inc.	$116M	$17.1 Million 0.0% of portfolio	7,111	Q2 2025 Added 18.64%
ENOB Enochian Biosciences Inc	$244M	$16 Million 0.0% of portfolio	55,447	Q2 2025 New
ARCT Arcturus Therapeutics Holdings Inc.	$396M	$13.1 Million 0.0% of portfolio	1,005	Q2 2025 New
RCKT Rocket Pharmaceuticals, Inc.	$220M	$13.1 Million 0.0% of portfolio	5,335	Q2 2025 New
OVID Ovid Therapeutics Inc.	$38.7M	$12.7 Million 0.0% of portfolio	38,382	Q2 2025 New
IGMS Igm Biosciences, Inc.	$37.7M	$12.5 Million 0.0% of portfolio	11,133	Q2 2025 New
CLDX Celldex Therapeutics, Inc.	$1.11B	$11.5 Million 0.0% of portfolio	566	Q2 2025 Reduced 68.52%
ALXO Alx Oncology Holdings Inc	$25.3M	$11.5 Million 0.0% of portfolio	27,709	Q2 2025 New
GBIO Generation Bio Co.	$239M	$11.2 Million 0.0% of portfolio	34,970	Q2 2025 New
IDYA Ideaya Biosciences, Inc.	$1.13B	$10 Million 0.0% of portfolio	476	Q2 2025 New
VRCA Verrica Pharmaceuticals Inc.	$327M	$7.27 Million 0.0% of portfolio	13,721	Q2 2025 New
PHVS Pharvaris N.V.	$712M	$6.49 Million 0.0% of portfolio	369	Q2 2025 New
GMAB Genmab A/S	$14.4B	$5.33 Million 0.0% of portfolio	258	Q2 2025 Reduced 23.21%
CDXC Chroma Dex Corp.	$420M	$5.07 Million 0.0% of portfolio	352	Q2 2025 New
PRTA Prothena Corp Public LTD CO	$354M	$2.79 Million 0.0% of portfolio	459	Q2 2025 New
FOLD Amicus Therapeutics, Inc.	$1.96B	$1.21 Million 0.0% of portfolio	211	Q2 2025 Reduced 98.15%
VRDN Viridian Therapeutics, Inc.\De	$717M	$617,000 0.0% of portfolio	44	Q2 2025 New
ALEC Alector, Inc.	$165M	$82,000 0.0% of portfolio	58	Q2 2025 Reduced 99.52%
FATE Fate Therapeutics Inc	$91.2M	$56,000 0.0% of portfolio	50	Q2 2025 New
SGMO Sangamo Therapeutics, Inc	$81.4M	$19,000 0.0% of portfolio	35	Q2 2025 Reduced 99.95%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.